Related Experiment Videos
Perioperative autologous blood donation in children
1Anesthesia Department, Children's Hospital Of Eastern Ontario, Ottawa, Canada. murto@cheo.on.ca
Insights
Autologous blood donation is safe and effective for children, reducing risks from allogeneic transfusions. Pediatric preoperative autologous donation (PAD) and related techniques offer significant benefits for blood conservation in pediatric patients.
Area of Science:
- Pediatric Anesthesiology
- Transfusion Medicine
- Pediatric Surgery
Background:
- Allogeneic blood transfusions in children carry risks, including pathogen transmission and alloimmunization.
- Autologous blood donation offers a safer alternative, mitigating lifelong complications.
- Pediatric preoperative autologous donation (PAD) is increasingly recognized as a standard of care.
Purpose of the Study:
- To evaluate the safety and efficacy of autologous blood donation strategies in pediatric patients.
- To assess the benefits of PAD, extreme isovolemic hemodilution (IHD), and intraoperative blood recovery in children.
- To determine the role of these methods in pediatric blood conservation programs.
Main Methods:
- Review of pediatric preoperative autologous donation (PAD) programs.
- Analysis of donor reaction, allogeneic exposure, and utilization rates.
- Assessment of patient resilience during extreme isovolemic hemodilution (IHD).
Main Results:
- Donor reaction and utilization rates in pediatric PAD programs are comparable or superior to adult data.
- Children demonstrate significant resilience during extreme isovolemic hemodilution (IHD).
- PAD, IHD, and intraoperative blood recovery are effective components of pediatric blood conservation.
Conclusions:
- Autologous blood donation, including PAD and IHD, is a safe and effective strategy for pediatric patients.
- These methods reduce reliance on allogeneic blood, minimizing associated risks.
- Further prospective, randomized studies are needed to define the optimal perioperative role of these techniques in children.
Abstract:
Autologous blood donation in children has become a standard of care. Children have to live with the life-time complications associated with allogeneic blood including the transmission of known and unknown pathogens, and the impact of alloimmunization on future blood transfusions, organ transplants and pregnancies. Donor reaction, allogeneic exposure and utilization rates in pediatric preoperative autologous donation (PAD) programs are as good if not better than reported in adult literature. Children are very resilient when undergoing extreme isovolemic hemodilution (IHD). PAD, IHD and intraoperative blood recovery appear to be useful components of a pediatric blood conservation program. Prospective, randomized studies addressing the specific needs of children are required to properly define their perioperative role.